Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perla R Colunga-Pedraza

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Case Reports in Hematology|December 15, 2025
Aggressive Sternum Extension in Diffuse Large B-Cell Lymphoma: Barriers to Timely Care in a Resource-Limited SettingAnahí Morales-Pedraza, Zulia Guzmán-Martínez, Ana C Tejada-Vásquez, et al.
Medicine|December 9, 2022
Thoracic ultrasound alone or in combination with tracheal amylase as a tool predictor of ventilator-associated pneumonia in neurocritical patientsRoberto Mercado-Longoria, Juan O Galindo-Galindo, Mario A Ataxca-Gonzalez, et al.
Annals of Hematology|February 1, 2011
Danazol as first-line therapy for aplastic anemiaJosé Carlos Jaime-Pérez, Perla R Colunga-Pedraza, Cynthia D Gómez-Ramírez, et al.
Transplant Immunology|November 16, 2023
Low-dose rituximab in steroid-refractory chronic graft-versus-host diseasePerla R Colunga-Pedraza, Luz María Barbosa-Castillo, Edgar Ulises Coronado-Alejandro, et al.
Leukemia & Lymphoma|January 29, 2015
Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experienceJosé Carlos Jaime-Perez, Perla R Colunga-Pedraza, César Homero Gutiérrez-Aguirre, et al.
Annals of Hematology|November 19, 2024
Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphomaPerla R Colunga-Pedraza, Héctor A Vaquera-Alfaro, Zulia Guzmán-Martínez, et al.
Blood Cells, Molecules & Diseases|February 21, 2013
Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplantJosé Carlos Jaime-Pérez, Perla R Colunga-Pedraza, Balbina Gutiérrez-Gurrola, et al.
Transplantation and Cellular Therapy|March 30, 2021
Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and FeasiblePerla R Colunga-Pedraza, Andrés Gómez-De León, Carlos Saúl Rodríguez-Roque, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 21, 2026
Mapping the Landscape of Quality of Life in Smoldering Multiple Myeloma Clinical Trials: A Systematic ReviewJosé Emiliano Montelongo-Cepeda, Sofía I Quezada-Ramírez, Hector A Vaquera Alfaro, et al.
British Journal of Haematology|November 24, 2024
Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot studyPerla R Colunga-Pedraza, Fernando De la Garza-Salazar, Héctor A Vaquera-Alfaro, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Case Reports in Hematology|December 15, 2025
Aggressive Sternum Extension in Diffuse Large B-Cell Lymphoma: Barriers to Timely Care in a Resource-Limited SettingAnahí Morales-Pedraza, Zulia Guzmán-Martínez, Ana C Tejada-Vásquez, et al.
Medicine|December 9, 2022
Thoracic ultrasound alone or in combination with tracheal amylase as a tool predictor of ventilator-associated pneumonia in neurocritical patientsRoberto Mercado-Longoria, Juan O Galindo-Galindo, Mario A Ataxca-Gonzalez, et al.
Annals of Hematology|February 1, 2011
Danazol as first-line therapy for aplastic anemiaJosé Carlos Jaime-Pérez, Perla R Colunga-Pedraza, Cynthia D Gómez-Ramírez, et al.
Transplant Immunology|November 16, 2023
Low-dose rituximab in steroid-refractory chronic graft-versus-host diseasePerla R Colunga-Pedraza, Luz María Barbosa-Castillo, Edgar Ulises Coronado-Alejandro, et al.
Leukemia & Lymphoma|January 29, 2015
Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experienceJosé Carlos Jaime-Perez, Perla R Colunga-Pedraza, César Homero Gutiérrez-Aguirre, et al.
Annals of Hematology|November 19, 2024
Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphomaPerla R Colunga-Pedraza, Héctor A Vaquera-Alfaro, Zulia Guzmán-Martínez, et al.
Blood Cells, Molecules & Diseases|February 21, 2013
Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplantJosé Carlos Jaime-Pérez, Perla R Colunga-Pedraza, Balbina Gutiérrez-Gurrola, et al.
Transplantation and Cellular Therapy|March 30, 2021
Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and FeasiblePerla R Colunga-Pedraza, Andrés Gómez-De León, Carlos Saúl Rodríguez-Roque, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 21, 2026
Mapping the Landscape of Quality of Life in Smoldering Multiple Myeloma Clinical Trials: A Systematic ReviewJosé Emiliano Montelongo-Cepeda, Sofía I Quezada-Ramírez, Hector A Vaquera Alfaro, et al.
British Journal of Haematology|November 24, 2024
Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot studyPerla R Colunga-Pedraza, Fernando De la Garza-Salazar, Héctor A Vaquera-Alfaro, et al.
Pageof 4